Elevance Health, Inc.
ELV
$417.25
$6.211.51%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -58.86% | -55.83% | 2.40% | 162.38% | -33.59% |
| Total Depreciation and Amortization | -202.13% | -1.79% | 1.21% | 226.82% | -161.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -202.22% | 138.63% | -159.90% | 270.48% | -84.74% |
| Change in Net Operating Assets | -101.45% | 163.53% | -97.87% | 77.32% | -2,174.29% |
| Cash from Operations | -73.63% | 498.88% | -77.40% | 166.58% | -213.70% |
| Capital Expenditure | 3.01% | -2.79% | -15.77% | 14.42% | -2.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | 99.64% | -6,322.22% | -77.78% |
| Divestitures | -- | -100.00% | -- | -- | -- |
| Other Investing Activities | 3,585.51% | 92.25% | 2.31% | -26.35% | -60.58% |
| Cash from Investing | -308.48% | 50.98% | 64.59% | -124.49% | -49.78% |
| Total Debt Issued | 10,393.75% | -96.41% | -14.34% | 360.77% | -- |
| Total Debt Repaid | -155.46% | -630.84% | 118.26% | -217.43% | 353.30% |
| Issuance of Common Stock | -66.67% | -20.00% | -38.14% | 142.50% | 29.03% |
| Repurchase of Common Stock | -2,648.48% | 85.75% | 30.48% | 28.23% | -93.33% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.32% | 0.00% | 0.26% | -9.54% | 0.57% |
| Other Financing Activities | -800.00% | -75.00% | 0.00% | 100.00% | -- |
| Cash from Financing | 253.88% | -236.98% | 1,987.50% | 108.12% | 60.36% |
| Foreign Exchange rate Adjustments | -214.29% | 240.00% | -- | -- | 125.00% |
| Miscellaneous Cash Flow Adjustments | -4,700.00% | 104.76% | -- | -- | -- |
| Net Change in Cash | -69.17% | 405.17% | 190.33% | 93.17% | -573.38% |
